ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.520
+0.120 (5.00%)
Sep 11, 2026, 5:28 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €40.49 million as of September 11, 2026. Its market cap has decreased by -47.64% in one year.
Market Cap
40.49M
Enterprise Value
41.43M
Revenue
10.53M
Ranking
n/a
PE Ratio
20.48
Stock Price
€2.52
ChartMarket Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 40.49M, an increase of 1,514.56%. That is a compound annual growth rate of 11.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 40.49M | -16.23% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.94B |
| EssilorLuxottica Société anonyme | 68.48B |
| Sartorius Stedim Biotech | 18.54B |
| Ipsen | 13.00B |
| Theraclion | 51.18M |
| MaaT Pharma | 50.03M |
| THX Pharma Société Anonyme | 48.01M |
| Fermentalg | 43.90M |